Risk of out-of-hospital cardiac arrest in antidepressant drug users

Autor: Talip E. Eroglu, Carlo A. Barcella, Thomas A. Gerds, Lars Vedel Kessing, Nertila Zylyftari, Grimur H. Mohr, Kristian Kragholm, Christoffer Polcwiartek, Mads Wissenberg, Fredrik Folke, Hanno L. Tan, Christian Torp‐Pedersen, Gunnar H. Gislason

Publikováno v: Eroglu, T E, Barcella, C A, Gerds, T A, Kessing, L V, Zylyftari, N, Mohr, G H, Kragholm, K, Polcwiartek, C, Wissenberg, M, Folke, F, Tan, H L, Torp-Pedersen, C & Gislason, G H 2022, ' Risk of out-of-hospital cardiac arrest in antidepressant drug users ', British Journal of Clinical Pharmacology, vol. 88, no. 7, pp. 3162-3171 . https://doi.org/10.1111/bcp.15224
British Journal of Clinical Pharmacology
British journal of clinical pharmacology, 88(7), 3162-3171. Wiley-Blackwell

Aim Conflicting results have been reported regarding the association between antidepressant use and out-of-hospital cardiac arrest (OHCA) risk. We investigated whether the use of antidepressants is associated with OHCA. Methods We conducted a nationw

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe31c3b3d2d6b8395131592bdb9ae7d2
https://curis.ku.dk/ws/files/310222127/Risk.pdf

Syndrome sérotoninergique consécutif à l'association d'escitalopram et de cyclosporine chez une patiente de 84 ans

Autor: Yasmine Hasso, Pierre Olivier Lang, Nicole Barbara Vogt-ferrier, Henriette Hilleret

Publikováno v: Revue de médecine interne, Vol. 29, No 7 (2008) pp. 583-586

Due to the stimulation of central and peripheral 5-hydroxytryptamine receptors, the serotonin syndrome is a potentially lethal situation. The large variety of its clinical manifestations leads to a difficult diagnosis. We describe the case of a serot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::728386b8132374a6f90ef85b33e47f18
https://archive-ouverte.unige.ch/unige:19211

Serotonin Syndrome after Concomitant Treatment with Linezolid and Citalopram

Autor: Richard Stern, Daniel Pablo Lew, Louis Bernard, Pierre Hoffmeyer

Publikováno v: Clinical Infectious Diseases, Vol. 36, No 9 (2003) P. 1197

Linezolid, a new synthetic antimicrobial, is an important weapon against methicillin-resistant Staphylococcus aureus (MRSA). Although there are reports of serotonin syndrome developing after concomitant use of linezolid and the selective serotonin re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20357b43e9cfe62a30b915cbcc9d98ad
https://doi.org/10.1086/374558